Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C13H21N3O7S2 and a molecular weight of approximately 395.45 g/mol. It is listed in DrugBank as DB03004 and classified as an experimental drug, with no current approvals or clinical trial activity reported. There is no available information on its mechanism of action, pharmacological class, or therapeutic indication[1][2]. The structure features an azetidine ring substituted with amino, carboxylic acid, methylsulfinyl, and sulfanyl groups.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2S)-2-amino-6-[[(3R,4R)-1-[(1S)-1-carboxy-2-[(S)-methylsulfinyl]ethyl]-2-oxo-4-sulfanylazetidin-3-yl]amino]-6-oxohexanoic acid.